Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?

This study has been completed.
Sponsor:
Information provided by:
Scranton-Temple Residency Program
ClinicalTrials.gov Identifier:
NCT00984841
First received: September 24, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted

September 24, 2009
September 24, 2009
January 2009
April 2009   (final data collection date for primary outcome measure)
Diabetes summary quality measure [ Time Frame: 4 months ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?
Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?"

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Diabetes care in the US is less than optimal. Some authors have found that targeted patient letters are also an effective tool to improve outcomes when they are part of a comprehensive disease management plan. Local patient satisfaction surveys had revealed that many patients had sub‐optimal understanding of diabetes measures and of the importance of controlling these measures to reduce diabetic complications. We wondered if tailored patient letters and enclosed lab orders when due might increase patient awareness of diabetes measures and increase patient engagement.We hypothesized that the addition of targeted patient letters with enclosed lab orders to an ongoing performance improvement program would further improve diabetes care.

We conducted a randomized controlled study of tailored patient letters and diabetes lab orders at our two resident‐based clinics.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Diabetes Mellitus
Other: Tailored letter
  • Experimental: Tailored letter
    Patients in the tailored letter group received by mail a tailored letter detailing their diabetes measures, together with enclosed orders for lab tests when due, and reminder of or scheduling for an office appointment.
    Intervention: Other: Tailored letter
  • Active Comparator: Usual Care
    Patients in the usual care group were part of a practice wide quality improvement process.
    Intervention: Other: Tailored letter
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
467
July 2009
April 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All active patients age 18 to 75 years with a diagnosis of diabetes mellitus were eligible.
  • An active patient was defined as one having an ICD‐9 code on the active problem list identifying the patient as diabetic, and a progress note in the EMR associated with an office visit within the prior 12 months.

Exclusion Criteria:

  • None
Both
18 Years to 75 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00984841
STRP001
No
John R Guzek, MD, Scranton-Temple Residency Program
Scranton-Temple Residency Program
Not Provided
Principal Investigator: John R Guzek, MD Scranton-Temple Residency Program
Scranton-Temple Residency Program
September 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP